Old Web
English
Sign In
Acemap
>
Paper
>
Bleeding Outcomes Using Novel Oral Anticoagulants (NOACs) in End-Stage Renal Disease (ESRD) Versus Coumadin
Bleeding Outcomes Using Novel Oral Anticoagulants (NOACs) in End-Stage Renal Disease (ESRD) Versus Coumadin
2021
Sheila Ann Kalathil
vinicius jorge
Irene S. Pakos
Ali Haydar
Drew H. Barnes
Kevin Bryan Lo
Claudia Dourado
Keywords:
end stage renal disease
Surgery
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]